The goal shifts from weight loss to weight maintenance and continued metabolic health
Part of the GLP1 agonists mechanism of action is slowing the stomach propulsion of its contents, and in turn, this allows some pills to have more time to get absorbed, leading to higher drug levels of meds like thyroid hormone
The Food and Drug Administration has recently approved the use of this molecule for the treatment of moderate to severe sleep apnea, opening a new path for patients who do not tolerate positive airway pressure ventilation [FDA]
You'd probably set up two groups of mice: a control group getting a simple saline solution and a test group receiving the CJC-1295/Ipamorelin blend
(For a separate analysis of MEDVi's GLP-1 weight loss program - including pricing structure, compounding classification, and the clinician-supervised prescribing process - read the full MEDVi GLP-1 program overview here
This ensures you receive personalized care tailored to your specific health needs and goals